Literature DB >> 22781764

[Multicenter study of disease attributes in adult patients with pulmonary hypertension].

Lin Dong1, Jian-guo He, Zhi-hong Liu, Xian-ling Lu, Wei-jie Zeng, Yun-juan Sun, Xin-hai Ni, Qing Gu, Zhi-hui Zhao, Xian-sheng Cheng, Chang-ming Xiong.   

Abstract

OBJECTIVE: To understand the demographic, hemodynamic and clinical features of adult patients with pulmonary hypertension (PH) in China.
METHODS: Between May 2007 and October 2010, a total of 551 adult PH patients were recruited from 31 clinical centers all over China. All fulfilled the traditional hemodynamic criteria diagnosed through right heart catheterization (RHC). The relevant data of demographic, clinical and hemodynamic features of all patients, analyzed the similarities and differences of demographic characteristics between different subtypes. They were divided into 2 groups: WHO functional class I/II and III/IV. And their hemodynamic and clinical features were compared.
RESULTS: There were 165 males and 386 females with a mean age of (35 ± 12) years. The mean body mass index (BMI) was (21 ± 4) kg/m(2). There were pulmonary arterial hypertension (PAH, n = 487) and chronic thromboembolic pulmonary hypertension (CTEPH, n = 64). Fatigue (421, 76.4%) and dyspnea (398, 72.2%) were the most common symptoms; Physical examination revealed such a common sign as an accentuated pulmonic second sound (P(2)) in 510 patients (92.6%). Over half (325, 59.0%) of them were of WHO functional class II and 213 (38.6%) patients functional class III. The 6-minute walking distance (6MWD) and Borg dyspnea score were (352 ± 91) m and 3.0 (2.0 - 4.0) respectively. ECG of 497 (90.2%) patients showed right ventricular hypertrophy. Mean right atrial pressure was (9 ± 6) mm Hg (1 mm Hg = 0.133 kPa), pulmonary arterial pressure (67 ± 20) mm Hg, cardiac index (2.7 ± 1.2) Lmin(-1)m(-2) and pulmonary vascular resistance (1496 ± 783) dyn.sec.cm(-5).
CONCLUSIONS: Young females with a low BMI are predominantly affected by PH. Severe functional and hemodynamic compromises often appear on presentation. And hemodynamic impairment is correlated with 6MWD and WHO functional class.

Entities:  

Mesh:

Year:  2012        PMID: 22781764

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  5 in total

1.  Population pharmacokinetics and the pharmacokinetic/pharmacodynamic relationship of riociguat in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.

Authors:  Soundos Saleh; Corina Becker; Reiner Frey; Wolfgang Mück
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

2.  Outline of the report on cardiovascular diseases in China, 2014.

Authors:  Chen Weiwei; Gao Runlin; Liu Lisheng; Zhu Manlu; Wang Wen; Wang Yongjun; Wu Zhaosu; Li Huijun; Zheng Zhe; Jiang Lixin; Hu Shengshou
Journal:  Eur Heart J Suppl       Date:  2016-05-24       Impact factor: 1.803

3.  Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparison.

Authors:  Chen Wang; Zhi-Cheng Jing; Yi-Gao Huang; Da-Xin Zhou; Zhi-Hong Liu; Christian Meier; Sylvia Nikkho; John Curram; Peng Zhang; Jian-Guo He
Journal:  Heart Asia       Date:  2016-05-17

4.  Retrospective cohort analysis of heart rate variability in patients with high altitude pulmonary hypertension in Tibet.

Authors:  Zhang Qian; Aili Fan; Binbin Pan
Journal:  Clin Cardiol       Date:  2019-12-19       Impact factor: 2.882

5.  Retinal vessel changes in pulmonary arterial hypertension.

Authors:  Mariana DuPont; Savanna Lambert; Antonio Rodriguez-Martin; Okaeri Hernandez; Mark Lagatuz; Taygan Yilmaz; Andrew Foderaro; Grayson L Baird; Patricia Parsons-Wingerter; Tim Lahm; Maria B Grant; Corey E Ventetuolo
Journal:  Pulm Circ       Date:  2022-02-15       Impact factor: 2.886

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.